hero section gradient
6 handpicked stocks

Incredibly Profitable Stocks

Invest in some of the world's most profitable companies, carefully selected by our professional analysts. These established market leaders have proven track records of strong financial performance and global influence.

Author avatar

Han Tan | Market Analyst

Published on May 19

Your Basket's Financial Footprint

Summary and key takeaways for the provided basket market capitalisation data.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and likely more stable, market-tracking returns.
  • Use this basket as a core, strategic holding rather than a speculative trade within a diversified portfolio.
  • Expect steady, long-term appreciation rather than short-term explosive gains; growth tends to be gradual.
Total Market Cap
  • AAPL: $3.90T

  • MSFT: $3.85T

  • AMZN: $2.37T

  • Other

About This Group of Stocks

1

Our Expert Thinking

These companies have mastered the art of generating substantial profits. Their strong track records, financial stability, and ability to weather economic downturns make them attractive investments, especially for those new to the market.

2

What You Need to Know

Companies in this group tend to have more stable share prices than those without consistent profits. Many also pay dividends, providing extra income while you hold their stock. Their financial cushion can help them survive challenging market conditions.

3

Why These Stocks

Each company in this selection has demonstrated exceptional ability to generate profits over time. They're established market leaders with global influence and strong financial performance, making them solid choices for investors looking for stability with growth potential.

Why You'll Want to Watch These Stocks

💰

Profit Powerhouses

These companies don't just make money—they generate billions in profits year after year. Their consistent financial strength can translate to long-term value for shareholders.

🛡️

Built to Last

When market conditions get tough, these profit leaders have the financial resources to weather the storm. Their stable foundations make them especially appealing for cautious investors.

🎯

The Smart Starting Point

Financial experts often recommend profitable, established companies like these for beginners. They offer a balance of stability and growth potential that's hard to match.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Frequently Asked Questions